The partners will be funded* as follows:
• National Foundation for Medical Research and Innovation (NFMRI): $1.29 million to advance medical innovations in the area of Alzheimer’s disease and cancer.
• Mater Foundation: $946,000 for research into children’s diseases, cancer and diabetes.
• Monash Partners: $904,000 for research to improve health for children, including those suffering with cancer, heart disease, and depression.
Jodi Kennedy, General Manager of Charitable Trusts and Philanthropy at Equity Trustees, said “we wanted groups that could bring together universities, medical research institutes, healthcare providers and industry. These three partners are recognised leaders in their respective fields.”
The Partnership Program is a new initiative created within Equity Trustee’s Medical Research and Health granting program. The 24 trusts are among those which Equity Trustees has sole discretionary responsibility as trustee.
NFMRI Chief Executive Officer, Dr Noel Chambers, said “he was proud NFMRI was selected as a partner following Equity Trustees’ robust selection and review process. NFMRI has worked hard to develop a unique capability and capacity to help advance medical research towards the development of new innovations including medicines, diagnostics, vaccines, devices and biologicals.”
* The final funded amount each year will depend on actual trust fund earnings, and may vary slightly. These amounts are calculated using prior year earnings as indicative.